GlassScriptPhysician profile
Vijay Borra
NPI 1356518146
$14,672.69
in general payments reported to CMS, 2019-2025
27 companies · $6,744 in 2025
The $6,744 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $149 · 2021: $916 · 2022: $731 · 2023: $745 · 2024: $4,705 · 2025: $6,744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,294 · Food and Beverage: $2,240 · Travel and Lodging: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,293.55 |
| Food and Beverage | $2,239.92 |
| Travel and Lodging | $1,660.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $9,599.77 | 2021-2025 | Velys, Actis |
| Depuy Synthes Sales INC. | $2,371.48 | 2019-2025 | Na, Monovisc, Orthovisc |
| Orthalign INC | $352.29 | 2022 | |
| Ethicon US, LLC | $325.79 | 2021-2025 | Vistaseal, Surgiflo Hemostatic Matrix, Stratafix |
| Bioventus LLC | $289.95 | 2019-2025 | Durolane, Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Argentum Medical | $248.35 | 2021 | |
| Pacira Therapeutics, INC. | $227.53 | 2019-2021 | |
| Smith+Nephew, INC. | $209.88 | 2021-2025 | Pico 14, Pico 7 |
| Sanara Medtech INC. | $205.74 | 2022 | |
| Davol INC. | $119.33 | 2025 | Arista, Surgiphor |
| Tactile Systems Technology INC | $107.79 | 2020-2025 | Nimbl, Flexitouch Plus |
| Si-Bone, INC. | $75.79 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $66.75 | 2022-2023 | Seglentis |
| Radius Health, INC. | $63.22 | 2019 | |
| Lifenet Health | $62.12 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $56.55 | 2022-2023 | Irrisept |
| Orthofix Medical, INC. | $56.16 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $50.84 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $43.09 | 2024 | T2 Alpha |
| Vertex Pharmaceuticals Incorporated | $24.66 | 2025 | |
| Organogenesis INC. | $22.26 | 2025 | Puraply Wound Matrix |
| Pfizer INC. | $20.38 | 2019 | |
| Rattan and Associates | $16.99 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $14.88 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.73 | 2022 | |
| Merck Sharp & Dohme LLC | $13.73 | 2022 | |
| Biocomposites INC | $12.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Borra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.